Drug recall

BD Regional Block Needles 22G x 1.50in (50 units/cs.). Indicated for administration of medications to affect…

FDA recall event 86994 · Class II · Becton Dickinson & Company

Key facts

Event ID 86994
Recall numbers Z-0923-2021, Z-0924-2021
Recalling firm Becton Dickinson & Company
Product type Devices
Products BD Regional Block Needles 22G x 1.50in (50 units/cs.). Indicated for administration of medications to affect anesthesia or analgesia to a specific anatomical location (region). Catalog No. 408348, BD Stimex Insulated Needle 22G x 2.13in ( 50 units/cs.) Indicated for administration of medications to affect anesthesia or analgesia to a specific anatomical location (region). Catalog No. 404204
Classification Class II
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall BD was advised by the European Notified Body, NSAI, that the instructions for use (IFU) needs to be updated to include the general contraindications
Initiation date Dec 9, 2020
Report date Feb 3, 2021
Termination date Aug 10, 2022
City Franklin Lakes
State NJ
Country United States
FEI number 2243072

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls